Clinical Trials Program

Changing Many Lives, One Trial at a Time

At Sidra Medicine, we are entrusted with the care of Qatar’s most precious resource – its children.

Our Clinical Trials Program offers a new lease of hope to young patients with rare and complex diseases. It focuses on clinical trials that will benefit children in the Arab region, particularly those with rare diseases that lack effective treatment.

The program embodies our commitment towards advancing pediatric healthcare and pioneering treatment protocols and therapies for the benefit of the people in Qatar and the region.

Our clinical services in partnership with our Research division, has identified a number of critical areas in pediatric health related to rare and genetic diseases to expand treatment options and redefining what is possible in pediatric medicine.

A historical lack of research particularly within the Arab population has led to a significant data gap, limiting the development of effective and personalized treatments for pediatric rare diseases. In fact, many current treatment options have shown reduced effectiveness in Middle Eastern, African and Persian populations because they have not been designed with these genetics in mind.

The Clinical Trial Program at Sidra Medicine will focus on representing Middle Eastern pediatric populations from the very beginning of the drug testing process.  It will play a crucial role in building a robust database of knowledge that will enable more effective and personalized treatment approaches tailored to the unique needs of the population.

Frequently Asked Questions

Clinical trials are the final step of medical research, where new treatments undergo careful evaluation for safety and effectiveness before being made widely available.

The trials could offer your child the chance to receive beneficial treatment whether it is a new drug therapy, device or procedure—before it becomes widely available. Your child’s participation could result in scientists discovering a more effective treatment for diseases that affect children all over the globe—and it could treat their disease more effectively than standard protocols.

Clinical trials serve as the backbone of medical advancements, offering a structured approach to evaluate the efficacy of new treatments. While not all clinical trials are successful in addressing or curing a disease, by enrolling your child in a clinical trial, will allow our team to find information that could help yours and other children.

Everyone who participates in clinical trials is a volunteer.

The outcome of your child’s clinical trial has the potential to positively impact the care, treatment and wellbeing of not only your child but that of many other children, not only in the same family but for families everywhere. It will also be a chance to help future patients. As a volunteer, your child is playing an important role in helping us find better ways to prevent, detect and treat diseases.

We work closely with the parents to empower them throughout the clinical trial process. Involving families in decision-making promotes shared responsibility, enhancing treatment adherence and outcomes. We become partners to ensure the best outcomes for your child.

By enrolling your children in research studies and clinical trials, families become partners in helping us develop the treatments of the future. It could benefit your family because it offers an opportunity to try a new medicine or treatment protocol or one that’s used in a new way.

We also recommend talking to your child’s doctor, your child, your family, and others in your support system. Having as much information as possible will help you make the right decision for your child.

Sidra Medicine’s clinical and Child Life teams have resources in place to help you explain to your child about the clinical trial process and how their care journey would look like.

For young children, they may even use pictures, props or videos to explain the process.

Each child’s legal guardian must give permission before the child is enrolled in a clinical trial. His or Her doctor and the clinical trials team may meet with the child to make sure they understand what the trial is about.

If the child is mature and shows adequate understanding, the team will ask for their written consent.

At Sidra Medicine, patient safety and well-being are the foremost concern.
Every clinical trial undergoes intense scrutiny, including review by an independent Institutional Ethical Board (IRB) and Qatar’s Ministry of Public Health (MOPH)—to ensure the protection of every patient enrolled, particularly vulnerable children.
The privacy and confidentiality of each family is strictly maintained throughout the journey. We have an informed consent process which adopts clear communication and ensures understanding of risks and benefits for both the patients and their guardians.
Your child’s involvement in a clinical trial is protected. Their name and family information will never be made public without your consent. This multi-layered approach, with multiple checkpoints throughout the process, guarantees adherence to the highest international ethical and scientific standards in clinical research.

Sidra Medicine is currently focusing on the following disorders and medical conditions:

• Endocrine disorders such as Congenital Hyperinsulinism (CHI), Diabetes Type 1 (TD1)
• Neuromuscular conditions like Spinal Muscular Atrophy (SMA)
• Metabolic disorders like Homocystinuria (HCU)
• Pediatric cancers like as Low Grade Glioma (pLGG)

Sidra Medicine will be conducting clinical trials that have either been approved for adults but not yet studied for children or have not yet been government approved. The trials will focus on either of the following:

• Medicines
• Medical devices
• Medical procedures

The capabilities of our clinical trials allow us to undertake complex research, including critical Phase 1 trials right up until Phase 4 studies. This follows years of excellence at diagnostic research where our teams made many fundamental discoveries in the cause and origin of diseases in our patients.

Phase 1: Phase 1 trials prioritize safety, testing a new treatment in a small group to assess side effects, dosage, and how it’s processed in the body.
Phase 2: Phase 2 trials evaluate effectiveness and refine treatment protocols in a larger group of patients with the target disease, while continuing safety monitoring.
Phase 3: Phase 3 trials compare the new treatment to existing options in a diverse and larger patient population, providing evidence for regulatory approval based on effectiveness and safety.
Phase 4: Phase 4 trials monitor long-term effects after a treatment is approved and available, ensuring ongoing safety evaluation and identifying any rare side effects or impacts over time.

Current clinical trials at Sidra Medicine

Sidra Medicine has been selected as a site for several pharma sponsored industry clinical trials to date, which are at various stages of feasibility assessment.

Trials currently active:

Condition/Disease: Congenital Hyperinsulinism (CHI)

RZ358-301 (SunRIZE):The purpose of the trial is to evaluate the efficacy and safety of RZ358 – an investigational product for the treatment of Congenital Hyperinsulinism (CHI) as add-on to standard-of-care (SOC) therapy compared to SOC alone.

The trial is currently being done in coordination with Sidra Medicine’s Endocrinology Outpatient and Inpatient wards and the Outpatient Infusion Centre (OPIC).Age group: ≥3 months-<18 years of age

 

Contact us

If you would like to speak to us about enrolling your child in a Clinical Trials Program, please email clinicaltrialsoffice@sidra.org